Bioventus Reports Second Quarter Financial Results; Introduces Full Year 2023 Financial Guidance
08 août 2023 07h30 HE
|
Bioventus, Inc.
DURHAM, N.C., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for...
Bioventus to Present at the Canaccord Genuity 43rd Annual Global Growth Conference
04 août 2023 08h30 HE
|
Bioventus, Inc.
DURHAM, N.C., Aug. 04, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Mark Singleton, senior vice president and chief...
Bioventus to Report Second Quarter of Fiscal Year 2023 Financial Results on August 8, 2023
01 août 2023 17h35 HE
|
Bioventus, Inc.
DURHAM, N.C., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report...
Bioventus Completes Divestiture of its Wound Business
23 mai 2023 07h30 HE
|
Bioventus, Inc.
DURHAM, N.C., May 23, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today that it has...
Bioventus Reports First Quarter Financial Results
16 mai 2023 16h15 HE
|
Bioventus, Inc.
DURHAM, N.C., May 16, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for...
Bioventus Reschedules Reporting of First Quarter Fiscal Year 2023 Financial Results to After Market Close on May 16, 2023
15 mai 2023 17h33 HE
|
Bioventus, Inc.
DURHAM, N.C., May 15, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will now report...
Bioventus Reschedules Earnings Call to May 16, 2023; Files for Extension to File Form 10-Q for the Period Ended April 1, 2023
11 mai 2023 07h00 HE
|
Bioventus, Inc.
DURHAM, N.C., May 11, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today the Company plans to...
Bioventus Announces Divestiture of its Wound Business
10 mai 2023 09h00 HE
|
Bioventus, Inc.
DURHAM, N.C., May 10, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today that it has signed a...
Bioventus to Report First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023
03 mai 2023 08h30 HE
|
Bioventus, Inc.
DURHAM, N.C., May 03, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report...
Bioventus Announces CEO Leadership Change
05 avr. 2023 08h00 HE
|
Bioventus, Inc.
DURHAM, N.C., April 05, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced that Ken M. Reali has...